Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 9/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | THRA | P10827 | 6/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.54 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.54 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.50 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL67525 | 0.96 | THRB (0.70) | THRBHPGDTSHRTHRAMEN1 | |
| SCHEMBL38654553 | 0.96 | THRB (0.70) | THRBHPGDTSHRTHRAMEN1 | |
| SCHEMBL26124058 | 0.93 | THRB (0.62) | THRBHPGDTSHRTHRAMEN1 | |
| SCHEMBL14907496 | 0.93 | THRB (0.62) | THRBHPGDTSHRTHRAMEN1 | |
| SCHEMBL9446718 | 0.92 | ALDH1A1 (0.66) | THRBHPGDTSHRTHRAMEN1 | |
| SCHEMBL14091318 | 0.92 | ALDH1A1 (0.66) | THRBHPGDTSHRTHRAMEN1 | |
| SCHEMBL10033661 | 0.92 | ALDH1A1 (0.66) | THRBHPGDTSHRTHRAMEN1 | |
| SCHEMBL14477492 | 0.92 | ALDH1A1 (0.66) | THRBHPGDTSHRTHRAMEN1 | |
| SCHEMBL14907516 | 0.91 | THRB (0.64) | THRBHPGDTSHRTHRAMEN1 | |
| SCHEMBL14088536 | 0.91 | THRB (0.57) | THRBHPGDTSHRTHRAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2568020-B1 | Ink set for forming multiple layers, ink jet recording method, and printed material | FUJIFILM CORP (JP) | 2017-02-01 | — | — | EP | disclosed |
| EP-2412765-B1 | Inkjet recording method, and printed material | FUJIFILM CORP (JP) | 2017-01-18 | — | — | EP | disclosed |
| EP-2568018-B1 | Ink set for forming multilayer, ink jet recording method, and printed material | FUJIFILM CORP (JP) | 2015-06-17 | — | — | EP | disclosed |
| US-8857968-B2 | Ink composition, ink container, and ink jet recording method | FUJIFILM CORPORATION (JP) | 2014-10-14 | — | — | US | disclosed |
| US-8857968-B2 | Ink composition, ink container, and ink jet recording method | FUJIFILM CORPORATION (JP) | 2014-10-14 | — | — | US | disclosed |
| US-20140199232-A1 | Targeted Therapeutic Nanoparticles | NANODERM SCIENCES, INC. (US) | 2014-07-17 | — | — | US | disclosed |
| US-8673431-B2 | Ink set for forming multilayer, ink jet recording method, and printed material | FUJIFILM CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| US-8673431-B2 | Ink set for forming multilayer, ink jet recording method, and printed material | FUJIFILM CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| US-8664297-B2 | Ink set for forming multiple layers, ink jet recording method, and printed material | FUJIFILM CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| US-8664297-B2 | Ink set for forming multiple layers, ink jet recording method, and printed material | FUJIFILM CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| US-8128843-B2 | Photocurable composition, photocurable ink composition, process for producing photocured material, and inkjet recording method | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| EP-2415607-A1 | Inkjet recording method, and printed material | FUJIFILM Corporation (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120026236-A1 | INKJET RECORDING METHOD, AND PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20100247797-A1 | PHOTOCURABLE COMPOSITION | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| EP-2233538-A1 | Photocurable composition | Fujifilm Corporation (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-20100015352-A1 | INK-JET INK COMPOSITION, AND INK-JET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2085439-A1 | Photocurable composition, photocurable ink composition, process for producing photocured material, and inkjet recording method | FUJIFILM Corporation (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-20090186163-A1 | PHOTOCURABLE COMPOSITION, PHOTOCURABLE INK COMPOSITION, PROCESS FOR PRODUCING PHOTOCURED MATERIAL, AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090087627-A1 | WHITE INK COMPOSITION, INKJET RECORDING METHOD, AND PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090081420-A1 | INK COMPOSITION, INKJET RECORDING METHOD, AND PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2009-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140199232-A1 | Targeted Therapeutic Nanoparticles | CD44, PHOSPHO1, CD47 | THRB 2909/4885HPGD 1881/4885TSHR 2364/4885 |
| US-20100247797-A1 | PHOTOCURABLE COMPOSITION | CCNT1, H1-0, NNT | THRB 3480/4885HPGD 2865/4885TSHR 3495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.